Aclaris Therapeutics Inc

10-Year Study

ACRS.US · Healthcare · US · Common Stock

Executive Summary: Aclaris Therapeutics Inc has compounded at -15.0% annually over the last 10 years, with a maximum drawdown of 97.2% and an annualized volatility of 129.4%.

1Y CAGR
+198.4%
3Y CAGR
-22.4%
5Y CAGR
-29.5%
10Y CAGR
-15.0%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
97.2%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.30
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.68
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
110.3%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2020 · +242.3%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2023 · -93.3%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
60%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202616.6-18.230.76.1————————32.2%
20250.0-19.8-23.1-9.85.8-2.77.726.1-1.632.612.36.421.4%
202410.52.64.2-2.4-14.96.821.8-11.9-2.557.4124.9-39.1136.2%
20237.3-26.3-35.19.9-6.124.2-4.8-24.2-8.4-27.3-82.420.0-93.3%
2022-24.936.415.7-28.53.89.110.43.2-1.1-0.8-2.53.58.3%
2021220.77.413.1-5.4-6.8-21.0-15.08.611.0-3.6-26.213.6124.7%
2020-34.4-8.1-8.827.96.014.932.714.44.549.4-13.093.7242.3%
2019-5.7-7.0-7.65.2-25.7-53.2-41.6-21.16.962.0-6.315.2-74.4%
2018-10.3-9.9-12.11.31.810.5-14.2-7.1-8.8-18.1-21.6-20.7-70.0%
2017-2.217.7-4.5-5.7-15.414.06.2-10.0-0.5-2.3-6.04.0-9.1%
2016———-2.58.1-7.66.72.327.0-17.040.9-9.443.2%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 129.4%. The dominant macroeconomic risk driver is LQD.US, accounting for 34.9% of variance. Idiosyncratic stock-specific factors contribute 33.9%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-019751.978891820581
2016-05-0110543.535620052771
2016-06-019746.701846965698
2016-07-0110395.778364116095
2016-08-0110638.522427440634
2016-09-0113514.511873350923
2016-10-0111213.72031662269
2016-11-0115804.749340369393
2016-12-0114321.899736147758
2017-01-0114000.000000000002
2017-02-0116480.211081794198
2017-03-0115736.147757255938
2017-04-0114833.77308707124
2017-05-0112548.812664907653
2017-06-0114311.345646437996
2017-07-0115197.889182058048
2017-08-0113683.377308707126
2017-09-0113620.05277044855
2017-10-0113303.430079155674
2017-11-0112511.873350923484
2017-12-0113013.192612137203
2018-01-0111672.823218997364
2018-02-0110522.427440633246
2018-03-019245.382585751979
2018-04-019366.754617414248
2018-05-019535.62005277045
2018-06-0110538.25857519789
2018-07-019044.854881266492
2018-08-018401.055408970977
2018-09-017662.269129287599
2018-10-016274.4063324538265
2018-11-014918.20580474934
2018-12-013899.7361477572563
2019-01-013678.1002638522427
2019-02-013419.525065963061
2019-03-013160.949868073879
2019-04-013324.538258575198
2019-05-012469.6569920844327
2019-06-011155.6728232189973
2019-07-01675.4617414248021
2019-08-01532.9815303430079
2019-09-01569.9208443271768
2019-10-01923.4828496042217
2019-11-01865.4353562005276
2019-12-01997.3614775725594
2020-01-01654.353562005277
2020-02-01601.5831134564644
2020-03-01548.8126649076518
2020-04-01701.8469656992086
2020-05-01744.0633245382586
2020-06-01854.8812664907653
2020-07-011134.5646437994724
2020-08-011298.1530343007917
2020-09-011356.2005277044855
2020-10-012026.3852242744063
2020-11-011762.532981530343
2020-12-013414.2480211081793
2021-01-0110949.868073878628
2021-02-0111757.255936675463
2021-03-0113298.153034300793
2021-04-0112585.751978891822
2021-05-0111736.147757255936
2021-06-019266.490765171504
2021-07-017878.6279683377315
2021-08-018554.089709762533
2021-09-019498.680738786281
2021-10-019155.672823218998
2021-11-016754.617414248022
2021-12-017672.823218997361
2022-01-015762.532981530343
2022-02-017862.796833773088
2022-03-019097.625329815302
2022-04-016501.319261213721
2022-05-016749.34036939314
2022-06-017366.754617414248
2022-07-018131.926121372032
2022-08-018395.778364116095
2022-09-018306.068601583114
2022-10-018237.467018469657
2022-11-018031.662269129289
2022-12-018311.345646437996
2023-01-018918.20580474934
2023-02-016575.197889182058
2023-03-014269.129287598945
2023-04-014691.292875989447
2023-05-014406.332453825858
2023-06-015472.295514511873
2023-07-015208.44327176781
2023-08-013947.229551451188
2023-09-013614.7757255936676
2023-10-012627.968337730871
2023-11-01461.58311345646445
2023-12-01554.0897097625331
2024-01-01612.137203166227
2024-02-01627.9683377308708
2024-03-01654.353562005277
2024-04-01638.5224274406332
2024-05-01543.5356200527705
2024-06-01580.4749340369394
2024-07-01707.1240105540898
2024-08-01622.6912928759895
2024-09-01606.8601583113456
2024-10-01955.1451187335093
2024-11-012147.7572559366754
2024-12-011308.707124010554
2025-01-011308.707124010554
2025-02-011050.131926121372
2025-03-01807.3878627968338
2025-04-01728.2321899736148
2025-05-01770.4485488126649
2025-06-01749.3403693931398
2025-07-01807.3878627968338
2025-08-011018.4696569920844
2025-09-011002.6385224274406
2025-10-011329.8153034300792
2025-11-011493.4036939313985
2025-12-011588.3905013192611
2026-01-011852.2427440633246
2026-02-011514.5118733509237
2026-03-011978.891820580475
2026-04-012100.263852242744
Annual Return Matrix
YearAnnual Return
2017-0.09137803979366255
2018-0.7003244120032441
2019-0.7442489851150202
20202.4232804232804233
20211.2472952086553324
20220.08321870701513068
2023-0.9333333333333333
20241.361904761904762
20250.21370967741935476
20260.3222591362126246
Total Factor Risk
1.2937107482722332
VTI.US Exposure
0.002141350337317675
VEA.US Exposure
0.005650832913682786
VWO.US Exposure
0.012734024772212612
QQQ.US Exposure
0.003665652613118285
VTV.US Exposure
0.007167305695980746
IJR.US Exposure
0.03603828275423165
QUAL.US Exposure
0.00819751073885813
SHV.US Exposure
0.10399842827632887
TLT.US Exposure
-0.0003724015864482468
LQD.US Exposure
0.34949008149388405
HYG.US Exposure
0.09550302633197147
GLD.US Exposure
-0.002317296215950872
USO.US Exposure
0.009561080035212109
VNQ.US Exposure
0.005973548862313956
BTC-USD.CC Exposure
-0.0020257153953568215
CPER.US Exposure
0.0018208224255820808
VIX.INDX Exposure
0.019272714472578178
UUP.US Exposure
-0.0007011834915066469
TIP.US Exposure
0.004938173602846422
Idiosyncratic Exposure
0.3392637613631436
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
129.4%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$508.6M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+12.5%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+52.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
12.1% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.68
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Aclaris Therapeutics Inc a high-risk investment?

Aclaris Therapeutics Inc (ACRS.US) has an annualized volatility of 129.4% and experienced a maximum drawdown of 97.2% over the last 10 years. Its primary macro risk driver is LQD.US.

What is the 10-year return of ACRS.US?

Over the past 10 years, ACRS.US has generated a Compound Annual Growth Rate (CAGR) of -15.0%. It has had a positive return in 60% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Aclaris Therapeutics Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest